3 results match your criteria: "Hospital Pharmacy Enterprices[Affiliation]"
Drugs commonly prescribed for heart rate control may induce adverse drug reactions in Alzheimer patients treated with acetylcholinesterase inhibitors (AChEIs). We have studied use of drugs with a known risk of Torsades de pointes (TdP) and drugs used to treat behavioral and psychological symptoms of dementia, as well as a combination of drugs with a known risk of TdP and drugs with a known heart rate-lowering effect, before and after initiating treatment with AChEIs. The study applied data from the Norwegian Prescription Database for the period 2004-2016.
View Article and Find Full Text PDFBackground/aims: The aim was to explore the impact of sex on prevalence, patterns and trends in the prescription of psychotropics and analgesics in users of acetylcholinesterase inhibitors (AChEIs), before and after AChEI initiation, compared to the general population.
Methods: A prospective study applying data from the Norwegian Prescription Database (NorPD) in the period 2004-2016. Prescription of antidepressants, antipsychotics, analgesics including opioids, benzodiazepines and z-hypnotics in persistent AChEI users was studied in a follow-up period from four years before to two years after AChEI initiation in men and women of four age groups: 37-64, 65-72, 73-80 and 81-88 years.
Limited effect of structured medication report as the only intervention at discharge from hospital.
Eur J Hosp Pharm
March 2019
Hospital Pharmacy Enterprices, South Eastern Norway, Oslo, Norway.
Objective: To investigate whether a structured medication report at discharge from the hospital could reduce the number of medication discrepancies in primary care.
Method: The study was performed as an open, randomised controlled study including patients transferred from one hospital in Norway to nursing home or home care. Both groups received epicrisis on discharge.